CD44 and Hematologic Malignancies

被引：0
|
作者：
Liu, Jianing [1 ]
Jiang, Guosheng [1 ]
机构：
[1] Shandong Acad Med Sci, Inst Basic Med, Dept Hematol Oncol, Jinan 250062, Shandong, Peoples R China
来源：
CELLULAR & MOLECULAR IMMUNOLOGY | 2006年 / 3卷 / 05期
关键词：
CD44; hematological malignancy; prognosis; therapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The expression of CD44 was upregulated in some hematological malignancies and is associated with metastasis and prognosis. The ligation of CD44 with specific monoclonal antibodies can trigger terminal differentiation of leukemic blasts in some subtypes, so it is probable to develop an anti-CD44 based differentiation therapy in leukemia. The effects of CD44 and its monoclonal antibodies are discussed in this review.
引用
收藏
页码：359 / 365
页数：7
相关论文
共 50 条
  • [1] CD44 and Hematologic Malignancies
    Jianing Liu1 and Guosheng Jiang1
    Cellular & Molecular Immunology, 2006, (05) : 359 - 365
  • [2] CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation
    Hu, Xiao-Tong
    Chen, Yun-Wen
    Liang, Anthony C. T.
    Au, Wing-Yan
    Wong, Kai-Yau
    Wan, Thomas S. K.
    Wong, Michelle L. Y.
    Shen, Lijun
    Chan, Ka-Kui
    Guo, Tianhuan
    Chu, Kent-Man
    Tao, Qian
    Chim, Chor-Sang
    Loong, Florence
    Choi, William W. L.
    Lu, Liwei
    So, Chi-Chiu
    Chan, Li Chong
    Kwong, Yok-Lam
    Liang, Raymond H. S.
    Srivastava, Gopesh
    BLOOD, 2010, 115 (12) : 2458 - 2461
  • [3] Perspectives of CD44 targeting therapies
    V. Orian-Rousseau
    H. Ponta
    Archives of Toxicology, 2015, 89 : 3 - 14
  • [4] Expression of CD44 variants in osteosarcoma
    Kuryu, M
    Ozaki, T
    Nishida, K
    Shibahara, M
    Kawai, A
    Inoue, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) : 646 - 652
  • [5] CD44 IN COLON-CANCER
    HERRLICH, P
    PALS, S
    PONTA, H
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) : 1110 - 1112
  • [6] CD44 expression in IgA nephropathy
    Florquin, S
    Nunziata, R
    Claessen, N
    van den Berg, FM
    Pals, ST
    Weening, JJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) : 407 - 414
  • [7] Expression of CD44 variants in osteosarcoma
    M. Kuryu
    T. Ozaki
    K. Nishida
    M. Shibahara
    A. Kawai
    H. Inoue
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 646 - 652
  • [8] Perspectives of CD44 targeting therapies
    Orian-Rousseau, V.
    Ponta, H.
    ARCHIVES OF TOXICOLOGY, 2015, 89 (01) : 3 - 14
  • [9] Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma
    Shibuya, Y
    Okabayashi, T
    Oda, K
    Tanaka, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (10) : 609 - 614
  • [10] The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
    Hassan, Wael Abdou
    Muqresh, Mohamad Ayham
    Omar, Mohamed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
12345